SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000882104-20-000047
Filing Date
2020-04-07
Accepted
2020-04-07 08:47:46
Documents
2
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_158626364825403.html 4/A  
1 FORM 4/A wf-form4a_158626364825403.xml 4/A 3613
2 POWER OF ATTORNEY /S/ NATHAN KRYSZAK, ATTORNEY-IN-FACT FOR EDWARD IMBROGNO ex-24.htm EX-24 3642
  Complete submission text file 0000882104-20-000047.txt   8710
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Imbrogno Edward (Reporting) CIK: 0001780493 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-19756 | Film No.: 20778503